TrialThe New England journal of medicine2023

Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.

Sapna P Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.